COMP <GO>
CELU vs CPHI // RETURN ON INVESTED CAPITAL (ROIC)
Celularity Inc. (Class A) (NASDAQ) VS. China Pharma Holdings Inc. (NYSE) • 15-METRIC TALLY: CELU 1
— CPHI 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CPHI
LAST: $0.80 (-5.79%) • MKT CAP: $27.6M
roic
-35.00%
LAST: $0.62 (-3.86%) • MKT CAP: $28.0M
roic
-11.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CELU VS. CPHI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CELU | CPHI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.40% | -3.20% | +27.60 | CELU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -11.40% | -23.60 | CPHI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 0.32% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -51.00% | -8.50% | -42.50 | CPHI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 4/9 | -3.00 | CPHI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.4 | 43.8 | -5.40 | CPHI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.6M | $28.0M | -$403.9K | CPHI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CELU REV | CPHI REV | CELU GROSS % | CPHI GROSS % | CELU FCF | CPHI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $26.6M | $4.1M | 24.4% | -3.2% | -$13.3M | $88.9K |
| FY 2024 | $54.2M | $4.5M | 72.4% | -43.8% | -$6.6M | -$444.5K |
| FY 2023 | $22.8M | $7.0M | — | — | -$38.7M | -$699.7K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CELU // BETA —
CPHI // BETA —